Exact Sciences (EXAS) announced the appointment of Aaron Bloomer as CFO, effective May 15. Bloomer brings to Exact Sciences more than 15 years of finance and accounting experience. He previously held leadership positions at Baxter International (BAX) and 3M (MMM), where he helped improve financial results, drove operational rigor, led strategic growth initiatives, played key roles in portfolio management, acquisitions, and divestitures, and set corporate strategy and vision. To help facilitate a smooth transition, Bloomer joins the company as executive vice president, finance, effective immediately, and will succeed Jeff Elliott following a 30-day transition period. As previously announced, Elliott will then transition to serving as special advisor to the CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
- Exact Sciences to supply individual cancer information to Mayo Clinic patients
- Exact Sciences removed from ‘Tactical Outperform’ list at Evercore ISI
- Citi opens ‘positive catalyst watch’ on Exact Sciences after competitor data
- Canaccord positive on Exact, Guardant after Freenome data
